What happened
DAE HWA Pharm disclosed a supply contract with Eucogen Pharma Sdn Bhd, worth US$7.19M, about 6.95% of its recent annual revenue, running through Sep 2026.
For context, this single contract equals about 6.95% of the company's most recent annual revenue.
| Counterparty | Eucogen Pharma Sdn Bhd |
|---|---|
| Contract value | US$7.19M |
| vs. recent revenue | 6.95% |
| Through | Sep 2026 (from Sep 2016) |
| Filed | 2026-09-07, Supply contract terminated |
| Source | DART rcept 20260907900530 → open original filing |
Source: DART. Information only, not investment advice.